Breast cancer

Open Access
Axillary surgery de-escalation for breast cancer in the era of precision medicine
Xueying Du, Xiao Sun, Yanbing Liu, Zhaopeng Zhang, Yongsheng Wang and Zhao Bi

Cancer Biology & Medicine August 2025, 22 (8) 871-873; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0255
Open Access
Breast surgeons at the forefront: preserving lymph nodes for enhanced immunotherapy efficacy
Zhiqiang Shi, Qiuchen Zhao, Yongsheng Wang and Pengfei Qiu

Cancer Biology & Medicine July 2025, 22 (7) 722-725; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0251
Open Access
Lactate and lactylation in breast cancer: current understanding and therapeutic opportunities
Lan Huang, Xuemei Chen, Meina Yan, Ze Xiang and Jian Wu

Cancer Biology & Medicine July 2025, 22 (7) 789-805; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0173
Open Access
High-precision immune-related plasma proteomics profiling predicts response to immunotherapy in patients with triple-negative breast cancer
Yuling Xiao, Hang Zhang, Yi Xiao, Ying Wang, Jing Zhang, Qi Hua, Pengchen Hu, Xinyan Lyu, Weihua Shou, Xin Hu, Zhiming Shao, Yizhou Jiang, Wei Huang and Jinxiu Shi

Cancer Biology & Medicine July 2025, 22 (7) 854-870; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0038
Open Access
Cancer cell-derived migrasomes harboring ATF6 promote breast cancer brain metastasis via endoplasmic reticulum stress-mediated disruption of the blood-brain barrier
Song Wang, Guohao Gu, Xinmiao Xian, Jun Li, Di Zhang, Jianran Guo, Anqi Zhang, Shen Chen, Dong Yan, Bingwu Yang, Meng An, Wei Zhang and Bo Fu

Cancer Biology & Medicine June 2025, 22 (6) 690-713; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0014
Open Access
Nuclear PHGDH regulates macrophage polarization through transcriptional repression of GLUD1 and GLS2 in breast cancer
Pei Wang, Xin Du, Zhiren Han, Jiaxin Zhong, Jiayu Yuan, Lin Jiang, Beinan Han, Wenkui Fu, Hongde Li, Hai Hu and Zhenkun Na

Cancer Biology & Medicine May 2025, 22 (5) 502-524; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0398
Open Access
The evidence and concerns about screening ultrasound for breast cancer
Huijiao Yan, Qiankun Wang, Fanghui Zhao, Daehee Kang and Youlin Qiao

Cancer Biology & Medicine April 2025, 22 (4) 295-300; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0562
Open Access
The treatment of breast cancer in the era of precision medicine
Jingwen Bai, Yiyang Gao and Guojun Zhang

Cancer Biology & Medicine April 2025, 22 (4) 322-347; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0510
Open Access
DB-1310, a HER3-targeting antibody-drug conjugate, has synergistic anti-tumor activity with trastuzumab in HER2- and HER3-expressing breast cancer
Xi Li, Liwen Liang, Zhongyuan Zhu, Haiqing Hua and Yang Qiu

Cancer Biology & Medicine March 2025, 22 (3) 231-236; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0586
Open Access
Antibody-drug conjugates in breast cancer: advances and prospects
Zhiqiang Shi, Yongjin Lu, Qiuchen Zhao, Yongsheng Wang and Pengfei Qiu

Cancer Biology & Medicine February 2025, 22 (2) 83-92; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0486

Main menu

User menu

Search

Breast cancer

Pages

Navigate

More Information

For Authors

Journal Services